CORMORANT ASSET MANAGEMENT, LP – Tarsus Pharmaceuticals, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$33.75M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+17.26%
quarter
Tarsus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +5.14% | 96.42K shares | 6.37M | $17.12 | 1.97M |
| Q2 2022 | share | Increase | +36.27% | 499.01K shares | 4.23M | $14.6 | 1.87M |
| Q1 2022 | share | Decrease | -1.95% | -27.34K shares | -8.43M | $16.82 | 1.37M |
| Q4 2021 | share | Decrease | -2.87% | -41.5K shares | 439K | $24 | 1.40M |
| Q3 2021 | share | Decrease | -4.59% | -69.43K shares | -12.74M | $21.55 | 1.44M |
| Q2 2021 | share | Decrease | -11.67% | -200K shares | -11.36M | $28.98 | 1.51M |
| Q1 2021 | share | 0.00% | 0 shares | -14.71M | $32.23 | 1.71M | |
| Q4 2020 | share | Increase | 0.00% | 1.71M shares | 69.96M | $41.33 | 1.71M |